Recent trend of clinical features in patients with hepatocellular carcinoma

Aim:  In this study, we evaluated the clinical characteristics of hepatocellular carcinoma (HCC) because the etiology of HCC has been changing recently.

[1]  R. Dhanasekaran,et al.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics , 2012, Hepatic medicine : evidence and research.

[2]  Kohjiro Ueki,et al.  Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.

[3]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[4]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[5]  S. Caldwell,et al.  The Natural History of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[6]  G. Farrell,et al.  A fresh look at NASH pathogenesis. Part 1: The metabolic movers , 2010, Journal of gastroenterology and hepatology.

[7]  G. Dore,et al.  Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden , 2009, Journal of viral hepatitis.

[8]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[9]  Yoshiyuki Suzuki,et al.  Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non‐B, non‐C liver cirrhosis: a cohort study , 2009, Journal of viral hepatitis.

[10]  Edward A Belongia,et al.  National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.

[11]  M. Taniai,et al.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.

[12]  K. Ikejima,et al.  Liver diseases and metabolic syndrome , 2008, Journal of Gastroenterology.

[13]  Y. Miura,et al.  Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus , 2008, Scandinavian journal of gastroenterology.

[14]  猪飼 伊和夫,et al.  第17回 全国原発性肝癌追跡調査報告(2002-2003) : 日本肝癌研究会追跡調査委員会 , 2007 .

[15]  K. Chayama,et al.  Feasibility of Freeze-Dried Sera for Serological and Molecular Biological Detection of Hepatitis B and C Viruses , 2006, Journal of Clinical Microbiology.

[16]  P. Conti,et al.  Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. , 2006, Annals of clinical and laboratory science.

[17]  G. Raimondo,et al.  Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients , 2006, Cancer.

[18]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  Tetsuji Sato,et al.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.

[20]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[21]  S. Caldwell,et al.  Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.

[22]  Akihiro Matsumoto,et al.  Hepatocellular carcinoma: recent trends in Japan. , 2004, Gastroenterology.

[23]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[24]  S. Locarnini.  Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[25]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[26]  Nash Crn.  Nonalcoholic steatohepatitis clinical research network , 2003, Hepatology.

[27]  Shohei Matsuzaki,et al.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background , 2003, Journal of Gastroenterology.

[28]  J. Hoofnagle,et al.  National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002 , 2002, Gastroenterology.

[29]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[30]  S. Tada,et al.  Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients. , 2002, Liver.

[31]  N. Ishimura,et al.  Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-γ production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity , 2000, American Journal of Gastroenterology.

[32]  新垣 美佐.  Role of hepatitis B virus in non-B,non-C chronic liver disease : in vitro proliferation and interferon-gamma production of peripheral blood monouclear cells in response to hepatitis B core antigen and its relation to hepatitis activity , 2000 .

[33]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[34]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[35]  Eugene R. Schiff,et al.  National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.

[36]  Y. Shiratori,et al.  Characteristic difference of hepatocellular carcinoma between hepatitis B‐ and C‐ viral infection in Japan , 1995, Hepatology.

[37]  A. Takada.  A new diagnostic criteria of alcoholic liver disease. , 1993 .

[38]  K. Tokunaga,et al.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. , 1991, Cancer research.

[39]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[40]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[41]  Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Report of a Who/idf Consultation Who Library Cataloguing-in-publication Data , 2022 .